Weekly News Recap #Phispers
EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer
This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...
Impressions : 3985
Apotex explores sale; Perrigo looks at selling prescription business; Takeda puts Latam biz on the block
This week, Phispers has good news for patients on sartan drugs.
For the first time since nitrosamine impurities were discovere...
Impressions : 7460
FDA chief Gottlieb resigns; BMS-Celgene deal may get derailed due to shareholder opposition
This week, Phispers brings you news about the sudden and unexpected resignation of the USFDA commissioner Scott Gottlieb, a day...
Impressions : 3396
FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation
In our final Phispers of 2018, we bring you news on how the big pharmaceutical companies in the US plan to ring in the new year...
Impressions : 5089
Aurobindo’s sartan banned in Europe; Dr. Reddy’s cost optimization drive continues, sells off another site
This week, Phispers brings you news from Dr. Reddy’s Laboratories in India which is divesting its API plant in Hyderabad ...
Impressions : 3871
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.